{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/impetigo/prescribing-information/flucloxacillin/","result":{"pageContext":{"chapter":{"id":"7ee4e706-9719-555b-85eb-18477604621b","slug":"flucloxacillin","fullItemName":"Flucloxacillin","depth":2,"htmlHeader":"<!-- begin field 45690c70-b2b4-4475-82c8-a47776cea102 --><h2>Flucloxacillin</h2><!-- end field 45690c70-b2b4-4475-82c8-a47776cea102 -->","summary":"","htmlStringContent":"<!-- begin item 235d0364-f800-4eff-a7cd-05eec8b0ea4d --><!-- end item 235d0364-f800-4eff-a7cd-05eec8b0ea4d -->","topic":{"id":"df142ae3-a675-5faa-955f-deba3aa176bc","topicId":"08c2a82c-2e88-477a-a00d-e75b47770e61","topicName":"Impetigo","slug":"impetigo","lastRevised":"Last revised in February 2020","chapters":[{"id":"5d5b7bff-ba78-5008-89df-49963bc208b7","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"35862574-df78-5554-bbe6-86275287ef3a","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"bc13ef99-c08d-5361-89de-765433a18ce3","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"8abd7c1c-e4d5-5fc6-9deb-2cfbbee04b6a","slug":"changes","fullItemName":"Changes"},{"id":"5105f48d-40d4-5c74-bec6-af0574471e5a","slug":"update","fullItemName":"Update"}]},{"id":"8c2bfe64-9ced-531b-b641-00b4ff18bd7c","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"eaefc2a4-19e1-525e-82f4-dccc7115b2b6","slug":"goals","fullItemName":"Goals"},{"id":"5a84c42b-0cca-52ed-9924-c54417494c01","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"5275b616-56f0-5b49-b2df-0cbffee7e3fc","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"6ed2c217-68c2-5ecc-8c61-7187fcbead1b","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"1dec750c-6e33-5adf-ae33-87a7f4a042c2","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"abff03ac-c7cc-5fe7-b6de-0871e4a2846a","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"ba37e0a2-65cd-52ec-8992-3299b96c1ea0","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"9440ce15-e09d-57c4-9ff1-70e323defaf3","slug":"definition","fullItemName":"Definition"},{"id":"605ba802-106d-5b36-93df-7644ebd9231d","slug":"causes","fullItemName":"Causes"},{"id":"863740f1-ab66-5109-bcb1-30ef774d0d2c","slug":"incidence","fullItemName":"Incidence"},{"id":"69d86930-4301-54ce-8d47-133d348f0b7b","slug":"prognosis","fullItemName":"Prognosis"},{"id":"afe26e4f-1499-57be-a412-9d17510303e9","slug":"complications","fullItemName":"Complications"}]},{"id":"cf492669-e436-53c8-b2b7-f369198b6622","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"8dee3a55-eaa2-5aab-b6e5-9a89ad394715","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"46b7f694-9523-5232-ad5d-ca6d1dba2c94","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"6e579521-48f9-59b3-a8e3-5e8e37473653","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"eebe4528-d9d4-5e2e-ab08-fe1255e1564b","fullItemName":"Management","slug":"management","subChapters":[{"id":"3f2b5528-3a31-51ee-9a7c-713b86cf2854","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"60f683cb-4447-5ecd-9b90-245b33e20336","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"f5f53214-ec8d-5ca7-8dde-0ef07d26b140","slug":"hydrogen-peroxide","fullItemName":"Hydrogen peroxide"},{"id":"178eb388-927e-59ea-8289-59bd71cf7ae0","slug":"fusidic-acid","fullItemName":"Fusidic acid"},{"id":"7ee4e706-9719-555b-85eb-18477604621b","slug":"flucloxacillin","fullItemName":"Flucloxacillin"},{"id":"58ff6676-3c7d-5610-98c3-5e6b6b326c5c","slug":"clarithromycin","fullItemName":"Clarithromycin"}]},{"id":"9983753e-f306-528c-bcad-5c5e37e49831","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"4825af9d-eb38-5c45-a29d-40a17e11e044","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"484c3649-34b0-537b-9431-0907ac172480","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"e05d1269-8a31-569f-b89a-f9609763db8b","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"c7093c62-22f3-531b-ab5c-3c222fd9220e","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"25fc1ec7-3a38-5636-9e71-37951cbae3e8","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"f7eec7c7-f55f-53ec-afb1-6fa00707cb90","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"9e2f110a-ec9f-5728-8f52-cb51f2bfe209","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"60f683cb-4447-5ecd-9b90-245b33e20336","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"ed4b3838-7fcf-548c-8bf2-1a2157544ffd","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field d74b188d-442b-4fd0-a57d-14a2dce54e37 --><h3>What are the contraindications and cautions for flucloxacillin?</h3><!-- end field d74b188d-442b-4fd0-a57d-14a2dce54e37 -->","summary":"","htmlStringContent":"<!-- begin item fe3b2dbf-7fe1-48fc-bc55-cbffcd71d150 --><!-- begin field 82d82428-2c20-4141-b0e6-26170149483f --><ul><li><strong>Do not prescribe flucloxacillin to people with:</strong><ul><li>Hypersensitivity to penicillin.</li><li>History of flucloxacillin-associated jaundice or hepatic dysfunction.</li></ul></li><li><strong>Prescribe flucloxacillin with caution in people with:</strong><ul><li>Hepatic dysfunction (not flucloxacillin-related), especially if they are 50 years of age or older, or have a serious underlying medical condition.</li><li>Severe renal impairment — dose adjustment may be required.</li><li>A history of allergy — these people are more likely to develop a sensitivity reaction.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/impetigo/references/\">ABPI, 2018b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/impetigo/references/\">BNF 76, 2018</a>]</p><!-- end field 82d82428-2c20-4141-b0e6-26170149483f --><!-- end item fe3b2dbf-7fe1-48fc-bc55-cbffcd71d150 -->","subChapters":[]},{"id":"8d10bdf1-fce9-5b21-9e74-de28de40c105","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field 008d2f3d-e23a-4a4c-b4fb-f107a250a80d --><h3>What key adverse effects are associated with flucloxacillin?</h3><!-- end field 008d2f3d-e23a-4a4c-b4fb-f107a250a80d -->","summary":"","htmlStringContent":"<!-- begin item ae68a989-9513-4b07-ad28-ca43232ebf55 --><!-- begin field 451325f5-4e6d-41f8-9363-35d7ad5d73d5 --><ul><li><strong>The adverse effects</strong><strong> of flucloxacillin include.</strong><ul><li><strong>Gastrointestinal </strong>— nausea and vomiting (common).<ul><li>Frequency not known: antibiotic-associated colitis — for more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/diarrhoea-antibiotic-associated/\">Diarrhoea - antibiotic associated</a>.</li></ul></li><li><strong>Nervous system</strong> — headache, dizziness (uncommon).</li><li><strong>Skin and subcutaneous tissue</strong> — skin rash, urticaria and purpura (uncommon).<ul><li>Very rarely: erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, generalised exanthematous pustulosis.</li></ul></li><li><strong>Other rare, or very rare adverse effects include:</strong><ul><li>Anaphylaxis.</li><li>Arthralgia and myalgia (very rare).</li><li>Hepatitis, cholestatic jaundice — this may occur up to several weeks after treatment with flucloxacillin has been stopped. Risk factors include treatment for more than 2 weeks, and increasing age.</li><li>Interstitial nephritis.</li><li>Neutropenia, thrombocytopenia, haemolytic anaemia.</li><li>CNS toxicity (including convulsions). A rare but serious adverse effect of the penicillins is encephalopathy which may result from high doses or in patients with severe renal failure.</li></ul></li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/impetigo/references/\">ABPI, 2018b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/impetigo/references/\">BNF 76, 2018</a>]</p><!-- end field 451325f5-4e6d-41f8-9363-35d7ad5d73d5 --><!-- end item ae68a989-9513-4b07-ad28-ca43232ebf55 -->","subChapters":[]},{"id":"4d074437-f70b-5542-86bc-82ff08d4c68b","slug":"interactions","fullItemName":"Interactions","depth":3,"htmlHeader":"<!-- begin field f4f6e0cc-4e75-455b-abf6-030d58fe8682 --><h3>What key interactions are associated with flucloxacillin?</h3><!-- end field f4f6e0cc-4e75-455b-abf6-030d58fe8682 -->","summary":"","htmlStringContent":"<!-- begin item d86bbd41-aa2c-42ab-9d8a-7c3c3ab83873 --><!-- begin field ff275ea6-2552-4bec-9ef2-34938fe45065 --><ul><li>Anticoagulants (for example, warfarin) — monitor prothrombin time or international normalised ratio closely — adjustment of anticoagulant dose may be needed.</li><li>Methotrexate — may reduce the excretion of methotrexate which can cause methotrexate toxicity – close monitoring required.</li><li>Probenecid — reduces the excretion of penicillin antibiotics.</li><li>Oral typhoid vaccine may be inactivated by flucloxacillin.</li><li>Oral hormonal contraception — additional contraceptive precautions are not required during or after courses of flucloxacillin.<ul><li>However, women should be advised about the importance of correct contraceptive practice if they experience vomiting or diarrhoea.</li><li>For further information, see the sections on vomiting or diarrhoea in the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-combined-hormonal-methods/\">Contraception - combined hormonal methods</a> and <a class=\"topic-reference external-reference\" href=\"/topics/contraception-progestogen-only-methods/\">Contraception - progestogen-only methods</a>.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/impetigo/references/\">ABPI, 2018b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/impetigo/references/\">BNF 76, 2018</a>]</p><!-- end field ff275ea6-2552-4bec-9ef2-34938fe45065 --><!-- end item d86bbd41-aa2c-42ab-9d8a-7c3c3ab83873 -->","subChapters":[]},{"id":"518f5a55-e2d1-5944-80d2-3249ed849f69","slug":"pregnancy-breastfeeding","fullItemName":"Pregnancy and breastfeeding","depth":3,"htmlHeader":"<!-- begin field bb50fd3f-673e-49d3-b8ce-302993d6a617 --><h3>Can I prescribe flucloxacillin to a woman who is pregnant or breastfeeding?</h3><!-- end field bb50fd3f-673e-49d3-b8ce-302993d6a617 -->","summary":"","htmlStringContent":"<!-- begin item cf813dd2-ef59-4a0e-a335-c9f7d0bfe0f4 --><!-- begin field 10b25c5a-b24e-4338-b892-5f30fcb1bb6e --><h4>Pregnancy</h4><ul><li style=\"list-style-type: none;\"><ul><li>The BNF states that flucloxacillin is not known to be harmful in pregnancy.</li><li>The UK Teratology Information Service (UKTIS) advises that flucloxacillin can be used in pregnancy as considerable clinical experience has not indicated adverse fetal effects.</li></ul></li></ul><h4>Breastfeeding</h4><ul><li style=\"list-style-type: none;\"><ul><li>Trace amounts of flucloxacillin are found in breastmilk — it is not known to be harmful to breastfed children.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/impetigo/references/\">UKTIS, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/impetigo/references/\">BNF 76, 2018</a>]</p><!-- end field 10b25c5a-b24e-4338-b892-5f30fcb1bb6e --><!-- end item cf813dd2-ef59-4a0e-a335-c9f7d0bfe0f4 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}